Zobrazeno 1 - 8
of 8
pro vyhledávání: '"azilsartan kamedoxomil"'
Autor:
Maddi N. V. D. Harikiran, Garaga Srinivas, Reddy Ambati V. Raghava, Sanasi Paul Douglas, Korupolu Raghubabu
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 30, Iss 1, Pp 31-35 (2017)
Azilsartan Kamedoxomil is an AT1-subtype angiotensin II receptor blocker (ARB). During the laboratory synthesis of Azilsartan Kamedoxomil, four related substances of Azilsartan Kamedoxomil were observed and identified. These were 2-Ethoxy-3-[[4-[2- [
Externí odkaz:
https://doaj.org/article/154c3d394f3b4ecea89030759d967a8a
Publikováno v:
ScienceRise: Pharmaceutical Science; No. 6(40) (2022); 21-28
ScienceRise: Pharmaceutical Science; № 6(40) (2022); 21-28
ScienceRise: Pharmaceutical Science; № 6(40) (2022); 21-28
The aim of the work is to consolidate azilsartan-kamedoxomil (AZM) into lipid matrix controlled-release microparticles to enhance its permeability because AZM belongs to Biopharmaceutical classification (BCS) IV which characterized by poor permeabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb918d00ce16dc3c36638b7c2078d5a
https://zenodo.org/record/7540689
https://zenodo.org/record/7540689
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raghubabu Korupolu, Ambati V. Raghava Reddy, Paul Douglas Sanasi, Srinivas Garaga, N. V. D. Harikiran Maddi
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 30, Iss 1, Pp 31-35 (2017)
Azilsartan Kamedoxomil is an AT1-subtype angiotensin II receptor blocker (ARB). During the laboratory synthesis of Azilsartan Kamedoxomil, four related substances of Azilsartan Kamedoxomil were observed and identified. These were 2-Ethoxy-3-[[4-[2- [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffb127b7aeab7a45ebf3b4ac7d2dd40
https://doi.org/10.1515/cipms-2017-0007
https://doi.org/10.1515/cipms-2017-0007
Publikováno v:
International Journal of Advanced Research. 4:1630-1639
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fd442694be064cdc00fa349fcb68077
https://doi.org/10.21474/ijar01/1973
https://doi.org/10.21474/ijar01/1973
Publikováno v:
International Journal of Advanced Research. 4:1377-1387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bca518ed71ff8433f1754990a8cef069
https://doi.org/10.21474/ijar01/1340
https://doi.org/10.21474/ijar01/1340
Autor:
Nimesh C. Misra, Korupolu Raghu Babu, Ambati V. Raghava Reddy, Chandiran Takshinamoorthy, Paul Douglas Sanasi, Srinivas Garaga, Koilpillai Joseph Prabahar
Publikováno v:
Organic Process Research & Development. 19:514-519
A commercially viable process for the preparation of azilsartan kamedoxomil, an angiotensin II receptor blocker, has been developed. The present work describes the novel synthesis of azilsartan medoxomil from amidoxime methyl ester. The present work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df7ba74023082e88c5d67c23867735a1
https://doi.org/10.1021/op500357r
https://doi.org/10.1021/op500357r
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.